Big Moving Stocks for Dec-16 Afternoon
These stocks are posting some big moves for today.
RMR Group Inc (The) (RMR) < (RMR) is currently trading at $15.07 + 3.18 (26.75%) on 173,640 shares traded. RMR Group Inc (The) (RMR) < is -- year-to-date, and -- over the last 12 months.
The RMR Group Inc is a holding company. The Company provides management services to four publicly owned real estate investment trusts, and three real estate operating companies.
Layne Christensen Company (LAYN) < (LAYN) is currently trading at $4.42 + 0.64 (16.93%) on 167,602 shares traded. Layne Christensen Company (LAYN) < is -53.67% year-to-date, and -44.61% over the last 12 months.
Layne Christensen Co is a water management, construction and drilling company. It provides solutions for water, mineral and energy challenges.
Intercept Pharmaceuticals Inc. (ICPT) < (ICPT) is currently trading at $162.00 + 22.32 (15.98%) on 869,373 shares traded. Intercept Pharmaceuticals Inc. (ICPT) < is +3.85% year-to-date, and +20.10% over the last 12 months.
Intercept Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of novel therapeutics to treat chronic liver disease utilizing its proprietary bile acid chemistry.
ContraFect Corp (CFRX) < (CFRX) is currently trading at $3.52 + 0.45 (14.66%) on 54,818 shares traded. ContraFect Corp (CFRX) < is +0.57% year-to-date, and +42.86% over the last 12 months.
ContraFect Corp is a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings. The Company’s product candidates are CF-30, CF-404.
Pacira Pharmaceuticals Inc. (PCRX) < (PCRX) is currently trading at $71.45 + 9.02 (14.45%) on 2,755,487 shares traded. Pacira Pharmaceuticals Inc. (PCRX) < is -19.41% year-to-date, and -21.01% over the last 12 months.
Pacira Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development, commercialization and manufacture of proprietary pharmaceutical products for use in hospitals and ambulatory surgery centers.
Akebia Therapeutics Inc (AKBA) < (AKBA) is currently trading at $11.89 + 1.45 (13.89%) on 548,285 shares traded. Akebia Therapeutics Inc (AKBA) < is +2.15% year-to-date, and +12.28% over the last 12 months.
Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.
Cyanotech Corporation (CYAN) < (CYAN) is currently trading at $5.69 + 0.56 (10.92%) on 820 shares traded. Cyanotech Corporation (CYAN) < is -17.89% year-to-date, and -4.21% over the last 12 months.
Cyanotech Corp cultivates and produces natural products derived from microalgae for the nutritional supplements market. The Company’s products include Spirulina Pacifica and natural astaxanthin.
UTStarcom Holdings Corp. (UTSI) < (UTSI) is currently trading at $2.51 + 0.24 (10.57%) on 1,303,208 shares traded. UTStarcom Holdings Corp. (UTSI) < is -11.31% year-to-date, and +0.39% over the last 12 months.
UTStarcom Holdings Corp is a telecom infrastructure provider. The Company is engaged in developing technology that will serve the rapidly growing demand for bandwidth from mobile, streaming and other applications.
GWG Holdings Inc (GWGH) < (GWGH) is currently trading at $6.00 + 0.55 (10.09%) on 2,841 shares traded. GWG Holdings Inc (GWGH) < is -11.24% year-to-date, and -34.92% over the last 12 months.
GWG Holdings Inc is a specialty finance company. The Company, through its subsidiaries finances the acquisition of life insurance policies and pays premiums through funds available on its credit facility.
Check-Cap Ltd (CHEK) < (CHEK) is currently trading at $2.15 + 0.19 (9.69%) on 1,000 shares traded. Check-Cap Ltd (CHEK) < is -- year-to-date, and -- over the last 12 months.
Check-Cap Ltd is a clinical stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for CRC screening.
